MedPath

Onzet

Brand Name: Onzet

Generic Name: Ondansetron (As Hydrochloride Dihydrate)

Active
Registration Number

DR-XY45574

Dosage Form

Solution For Injection (I.M./I.V.)

Issuance Date

March 31, 2021

Expiry Date

August 24, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength2 mg / mL (8 mg / 4 mL)
Packaging5 mL-Capacity, 4 mL-net content Type I Clear and Colorless Glass Ampoule (Box of 10's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Ondansetron (As Hydrochloride Dihydrate)Active
Monograph: ondansetron (as hydrochloride dihydrate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform